PofoliaShared via Pofolia

ACS Omega· 2026Q1

Exploring Hippuric Acid’s Putative Protective Role in Aging through In Silico and In Vitro Screening

Domenico Gadaleta, Sofia Ghironi, Federica Maggi, Melissa Tiddia et al.

Short summary

Hippuric acid (HA), a metabolite linked to healthy aging, may exert protective effects by modulating specific proteins like transporters and epigenetic regulators, rather than through general antioxidant or anti-inflammatory actions.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Hippuric acid (HA) is linked to healthy aging, but its active role is unclear.
  • In silico and in vitro screening identified potential HA targets: transporters, epigenetic regulators (HDACs), and enzymes in inflammation/proteostasis.
  • HA analogues showed potency in the low-micromolar or nanomolar range for these targets.
  • Direct antioxidant or anti-inflammatory activity of HA was found to be limited.
  • Results suggest HA's aging protection may involve specific protein modulation rather than general pathways.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Hippuric acid (HA) is a diet- and microbiome-derived metabolite consistently associated with healthy aging, yet whether it is a passive biomarker or an active effector remains unresolved. To investigate mechanisms underlying its protective role, in silico screening of large bioactivity data sets was performed and integrated with results from in vitro assays. A multifingerprint similarity approach was employed to identify close HA analogues and their reported targets. HA analogues were identified with reported potencies in the low-micromolar or nanomolar range toward transporters (solute carriers, organic anion transporters, multidrug resistance-associated proteins), epigenetic regulators (histone deacetylases), and enzymes linked to inflammation, proteostasis, or vascular homeostasis (carbonic anhydrases, cyclooxygenase-2, soluble epoxide hydrolase, neprilysin). Additional evidence pointed to proteins involved in detoxification, energy metabolism, and neurodegeneration (kynureninase, microtubule-associated protein tau, 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase), supporting their plausibility as candidate HA targets. By contrast, database screenings for direct antioxidant or anti-inflammatory activity were mostly inconclusive, whereas in vitro assays suggested limited radical-scavenging activity and no modulation of nitric oxide production pathways. Results suggest that HA’s protective associations with aging might involve modulation of specific proteins or transporter-mediated mechanisms, rather than acting solely through target-nonspecific pathways. While these findings remain exploratory and require further confirmation, this integrated in silico and in vitro analysis provides an initial, hypothesis-generating strategy to narrow the spectrum of potential molecular interactions, offering candidate targets to guide future functional in silico, in vitro, and in vivo validation experiments.

The authors' abstract, as published at the source. ACS Omega, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Biochemistry (Biochemistry, Genetics and Molecular Biology)

BiochemistryBiochemistry, Genetics and Molecular Biology